The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2- induced radioresistance in HeLa cells expressing wild-type RAS

Radiation Research

Volumn 152, Issue 4, 1999, Pages 404-411

  Cohen Jonathan, Elizabeth ^a,b   Toulas, Christine ^a   Ader, Isabelle ^a   Monteil, Sylvia ^a   Allal, Cuider ^a   Bonnet, Jacques ^b   Hamilton, Andrew D ^c   Sebti, Said M ^d   Daly Schveitzer, Nicolas ^b   Favre, Gilles ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b Lab de Pharmacocinétique   (France)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE METHYL ESTER; PROTEIN FARNESYLTRANSFERASE INHIBITOR;

ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; RADIOSENSITIZATION;

ALKYL AND ARYL TRANSFERASES; CELL SURVIVAL; ENZYME INHIBITORS; FARNESYLTRANSTRANSFERASE; FIBROBLAST GROWTH FACTOR 2; HELA CELLS; HUMANS; METHIONINE; RADIATION TOLERANCE;

EID: 0032874281     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3580225     Document Type: Article

References (37)

1. M. Sklar, The ras oncogenes increase the intrinsic radioresistance of NIH 3T3 cells to ionizing radiation. Science 239, 645-647 (1988).
2. 2 delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and v-myc. Radiat. Res. 125, 283-287 (1991).
3. W. G. McKenna, E. J. Bernhard, D. A. Markiewicz, M. S. Rudoltz, A. Maity and R. J. Muschel, Regulation of radiation-induced apoptosis in oncogene-transfected fibroblasts: influence of H-ras on the G2 delay. Oncogene 12, 237-245 (1996).
4. A. Haimovitz-Friedman, I. Vlodavsky, A. Chaudhuri, L. Witte and Z. Fuks, Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res. 51, 2552-2558 (1991).
5. A. Haimovitz-Friedman, N. Balaban, M. McLoughlin, D. Ehleiter, J. Michaeli, L. Vlodavsky and Z. Fuks, Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res. 54, 2591-2597 (1994).
6. Z. Fuks, R. S. Persaud, A. Alfieri, M. McLoughlin, D. Ehleiter, J. L. Schwartz, A. P. Seddon, C. C. Cordon and A. Haimovitz-Friedman, Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res. 54, 2582-2590 (1994).
7. N. Renko, N. Quarto, T. Morimoto and D. B. Rifkin, Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J. Cell. Physiol. 144, 108-114 (1990).
8. H. Prats, M. Kaghad, A. C. Prats, M. Klagsbrun, J. Ielias, P Liauzun, P. Chalon, J. P. Tauber, F. Amalric, J. Smith and D. Caput, High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG. Proc. Natl. Acad. Sci. USA 86, 1836-1840 (1989).
9. B. Couderc, H. Prats, F. Bayard and F. Amalric, Potential oncogenic effects of basic fibroblast growth factor requires cooperation between CUG and AUG-initiated forms. Cell Regul. 2, 708-718 (1991).
10. B. Bugler, F Amalric and H. Prats, Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol. Cell. Biol. 11, 543-547 (1991).
11. A. Bikfalvi, S. Klein, G. Pintucci, N. Quarto, P. Mignatti and D. B. Rifkin, Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular forms. J. Cell. Biol. 129, 233-243 (1995).
12. 2 delay and an hyperphosphorylation of p34cdc2 in HeLa cells. Cancer Res. 57, 1364-1370 (1997).
13. P. Adamson, C. J. Marshall, A. Hall and P. A. Tilbrook, Post translational modifications of p21 rho proteins J. Biol. Chem. 267, 20033-20038 (1992).
14. E. C. Lerner, Y. Qian, M. A. Blaskovich, R. D. Fossum, A. Vogt, J. Sun, A. D. Cox, C. J. Der, A. D. Hamilton and S. M. Sebti, Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. J. Biol. Chem. 270, 26802-26806 (1995).
15. J. Sun, Y. Qian, A. Hamilton and S. Sebti, Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-ras mutation and p53 deletion. Cancer Res. 55, 4243-4247 (1995).
16. 2-M enrichment in A549 cells. Cancer Res. 57, 1846-1850 (1997).
17. A. Vogt, J. Sun, Y. Qian, A. Hamilton and S. M. Sebti, The geranylgeranyltransferase-I inhibitor GGTI-298 arrests human tumor cells in G0/G1 and induces p21(WAF/CIP1/SD11) in a p53-independent manner. J. Biol. Chem. 272, 27224-27229 (1997).
18. P. F. Lebowitz, P. J. Casey, G. C. Prendergast and J. A. Thissen, Farnesyltransferase inhibitors alter the prenylation and the growth-stimulating function of RhoB. J. Biol. Chem. 272, 15591-15594 (1997).
19. E. J. Bernhard, G. Kao, A. D. Cox, S. M. Sebti, A. D. Hamilton, R. J. Muschel and W. G. McKenna, The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts Cancer Res. 56, 1727-1730 (1996).
20. B. Fertil, H. Dertinger, A. Courdi and E. Malaise, Mean inactivation dose: A useful concept for intercomparison of human cell survival curves. Radiat. Res. 99, 73-84 (1984).
21. E. J. Bernhard, R. J. Muschel, V. J. Bakanauskas and W. G. McKenna, Reducing the radiation-induced G2 delay causes HeLa cells to undergo apoptosis instead of mitotic death. Int. J. Radiat. Biol. 69, 575-584 (1996).
22. R. Lock, O. Galperina, R. Feldhoff and L. Rhodes, Concentration-dependent differences in the mechanisms by which caffeine potentiates etoposide cytotoxicity in HeLa cells. Cancer Res. 54, 4933-4939 (1994).
23. E. Miranda, C. Santana, E. Rojas, S. Hernandez, P. Ostrosky-Wegman and A. Garcia-Carranca, Induced mitotic cell death of HeLa cells by abnormal expression of c-H-ras. Mutat. Res. 349, 173-182 (1996).
24. S. Armstrong, V. Hannah, J. Goldstein and M. Brown, CAAX geranylgeranyltransferase transfers farnesyl as efficiently as geranylgeranyl to RhoB. J. Biol. Chem. 270, 7864-7868 (1995).
25. P. De Cremoux, C. Gauville, V. Closson, G. Linares, F. Calvo, A. Tavitian and B. Olofsson, EGF modulation of the ras-related rhoB gene expression in human breast-cancer cell lines. Int. J. Cancer 59, 408-415 (1994).
26. D. Jahner and T. Hunter, The ras-relaled gene rhoB is an immediate early gene inducible by ν-fps, epidermal growth factor and platelet derived growth factor in rat fibroblasts. Mol. Cell. Biol. 11, 3682-3690 (1991).
27. G. Fritz, B. Kaina and K. Aktories, The Ras-related small GTP-binding protein RhoB is immediate-early inducible by DNA damaging treatments. J. Biol. Chem. 270, 25172-25177 (1995).
28. R. B. Lock, O. V. Galperina, R. C. Feldhoff and L. I. Rhodes, Concentration-dependent differences in the mechanisms by which caffeine potentiates etoposide cytotoxicity in HeLa cells. Cancer Res. 54, 4933-4939 (1994).
29. W. Zhen and A. Vaughan, Effect of caffeine on radiation-induced apoptosis in TK6 cells. Radiat. Res. 141, 170-175 (1995).
30. 2/M block in murine T-lymphoma cells. Radiat. Res. 141, 235-243 (1995).
31. S. Barni, G. Bernoechi, E. Scherini and V. Mares, Growth and polyploidization of the liver of early postnatal rats treated with bleomycin. Cell. Biol. Int. Rep. 9, 933-1002 (1985).
32. V. Rodilla, Origin and evolution of binucleated cells and binucleated cells with micronuclei in cisplatin-treated CHO cultures. Mutat. Res. 300, 281-291 (1993).
33. S. Aggarwal, Inhibition of cytokinesis in mammalian cells by cis-dichloro-diammine-platinum (II). Cytobiologie 8, 395-452 (1974).
34. A. Sodhi, Origin of giant cells in regressing sarcoma 180 after cis dichlorodiammineplatinum (II) treatment, a fine structural study. J. Clin. Hematol. Oncol. 7, 569-579 (1977).
35. B. Searle and S. Bloom, Influence of the bn gene on mitosis of immature red blood cells in turkey. J. Hered. 70, 155-160 (1979).
36. V. Peyrot, C. Briand, R. Momburg and J. Sari, In vitro mechanism study of microtubule assembly inhibition by cis-dichlorodiammine-platinum (II). Biochem. Pharmacol. 35, 371-375 (1986).
37. A. Joy, J. Moffet, K. Neary, E. Mordechai, E. K. Stachoviak, S. Coons, J. Rankin-Shapiro, R. Z. Florkiewicz and M. K. Stachowiak, Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells. Oncogene 14, 171-183 (1997).